BOUL — Boule Diagnostics AB Cashflow Statement
0.000.00%
- SEK316.76m
- SEK489.17m
- SEK558.46m
- 34
- 45
- 48
- 34
Annual cashflow statement for Boule Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -5.93 | 36 | 29 | 39.3 | -350 |
Depreciation | |||||
Non-Cash Items | 31.4 | -2.03 | -4.11 | 29.6 | 392 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 28.3 | -12.2 | -63.4 | -17.5 | -18.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 75.2 | 43.3 | -11.4 | 51.4 | 46.6 |
Capital Expenditures | -4.58 | -3.15 | -6.43 | -6.87 | -8.9 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -41.4 | -53.2 | -68.5 | -75.8 | -77 |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -46 | -56.4 | -75 | -82.7 | -85.9 |
Financing Cash Flow Items | 0.001 | -0.001 | -10.3 | -0.56 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -14.9 | 15.8 | 141 | -25.5 | 24.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 11.4 | 5.19 | 58.7 | -59.6 | -14.6 |